High blood pressure and heart failure threaten the lives of numerous people here in Ohio and across the country. Unfortunately, some of the most prescribed medications for these conditions include valsartan as an ingredient, which became the subject of recalls in 2018 after it was discovered it contained an impurity identified as a probable human carcinogen. After more than a year since manufacturers began recalling medication containing this ingredient, the Food and Drug Administration is still discovering faulty manufacturing processes.
Numerous prescription and over the counter medications have been recalled due to the presence of a probable human carcinogen called N-Nitrosodimethylamine and referred to as NDMA. The recalls began with valsartan and losartan, which are popular blood pressure medications, and then expanded to over the counter heartburn medications including Zantac and its generic equivalent ranitidine. Now, Valisure, a online pharmacy, is asking the Food and Drug Administration to recall metformin, a widely used diabetes drug.
You expect that when your Ohio doctor prescribes you a medication, it is safe for you to take. Unfortunately, it has become clear that is not always the case. More medications, including those containing ranitidine, can put your long-term health at risk due to the presence of N-nitrosodimethylamine (NDMA), which is a human carcinogen.
People in Ohio and across the country have become used to hearing about prescription drugs subject to recalls for one reason or another. However, since the recall of the widely popular over-the-counter medication Zantac kicked off several recalls of ranitidine heartburn medications, concern has been raised about other drugs people use every day and can buy at nearly any store. These fears may be well-founded if a state on the west coast has anything to say about it.
Toward the end of 2019, consumers in Ohio and elsewhere learned that a popular medication some have taken for decades contained a human carcinogen that could give them a variety of cancers. Since Sept. 2019, numerous pharmaceutical companies have voluntarily issued recalls for products containing ranitidine, a popular heartburn reliever. Some people may have hoped that the new year would bring better news, but instead, the Food and Drug Administration only continues to widen heartburn drug recalls.
It has been widely publicized across the country fact that N-nitrosodimethylamine (NDMA) could cause cancer in people who take ranitidine products. Up to this point, the Zantac recall has not urged those who take it to stop doing so. That has changed.
Numerous countries decided to simply discontinue the manufacturing, distribution and selling of Zantac and its generic equivalents off the market. Here in the United States, the Food and Drug Administration decided to continue testing and determining how nitrosodimethylamine, popularly known as NDMA, forms in the medication. In the meantime, consumers here in Ohio and elsewhere may be wondering whether they will suffer harm from ranitidine.
Many Ohio residents take dietary supplements for a variety of reasons. Part of the problem with the supplements is that they do not undergo testing necessarily undergo the same scrutiny by the Food and Drug Administration as prescribed medications do, which means they are often classified as unapproved drugs, especially if they contain medications ordinarily prescribed by doctors. The recent recall of a dietary supplement claiming to help with libido occurred because it contained an unapproved drug.
If you are like many other heartburn sufferers here in Ohio, you probably take an over the counter medication for relief. If your medication of choice happens to be Zantac, whose generic version is called Ranitidine, the Food and Drug Administration says you could end up with cancer. According to the FDA, this heartburn medication contains approximately 26,000 times the acceptable level of N-nitrosodimethylamine.
When a recall is announced, people here in Ohio and elsewhere need to understand how dangerous the product in question is. The Food and Drug Administration developed a system to identify the severity of the problem. The most dangerous classification the FDA has is a Class I recall, which means the potential for fatalities is high.